Eptazocine hydrobromide

This classification denotes an analgesic agent with the molecular structure C15H21NO.BRH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 865626Y4ON chemically known as 1,6-methano-1h-4-benzazonin-10-ol, 2,3,4,5,6,7-hexahydro-1,4-dimethyl-, hbr (1:1), (1s,6s)-, but more commonly known as eptazocine hydrobromide, which bears US NIH Compound Identifier 155705. European Medicines Agency schedules Eptazocine hydrobromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01924MIG. Most nations, for tariff and trade purposes, schedule eptazocine hydrobromide under HS 29339930 and SITC 51577. As of Q4 2014, EPTAZOCINE HYDROBROMIDE remains US FDA's Preferred Term for this commodity. Eptazocine hydrobromide bears US NLM identifiers UMLS ID C0124847 and NCI Concept Code C96732. SMILES: C[C@@]12CCN(C[C@@H](C1)CC3C2CC(CC3)O)C.BR.